2:1 Atrioventricular Block After Upgrade From DDD to CRT-D.
Jingfang Cui1, Ji Li1, Yongjia Li1
1Department of Cardiology, Bethune International Peace Hospital, Shijiazhuang, China.
JACC. Case Reports
|February 26, 2026
Summary
Cardiac resynchronization therapy with defibrillator (CRT-D) can be complicated by T-wave oversensing, leading to suboptimal pacing. This case highlights the importance of troubleshooting oversensing to ensure effective biventricular pacing for heart failure management.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- High burden of right ventricular pacing can cause pacing-induced cardiomyopathy.
- Cardiac resynchronization therapy with defibrillator (CRT-D) utilizes biventricular pacing to treat heart failure.
- Optimal clinical response to CRT-D requires a high percentage of biventricular pacing.
More Related Videos
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
672
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
672
Cardiomyopathy II: Dilated Cardiomyopathy
667
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
2.4K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.4K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
702
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
702
Disturbances in Heart Rhythm
3.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.3K
Dysrhythmias VI: Management of Dysrhythmias
544
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
544


